PRIMR

PRIMR PRIMR creates simple illustrated videos to educate patients about cancer and clinical trials.

04/22/2026

🎯 Standard treatments like surgery or full radiation are effective but can cause long-term side effects. The IRRADIANT study explores a new "boost" method using electrical pulses (IRE) to target only the aggressive cancer cells, aiming to protect your quality of life while controlling the disease.

Watch the IRB-approved video here:
https://www.primrmed.com/cancer-clinical-trials/irradiant



Produced in partnership with Memorial Sloan Kettering Cancer Center | Himanshu Nagar | AngioDynamics | The Nano Knife System.

New clinical trial video! 📢The IRRADIANT trial is evaluating a new approach for intermediate-risk prostate cancer. The s...
04/22/2026

New clinical trial video! 📢

The IRRADIANT trial is evaluating a new approach for intermediate-risk prostate cancer. The study compares a standard radiation "boost" to a newer technique called irreversible electroporation (IRE), aiming to provide effective cancer control with fewer long-term side effects.

Watch the IRB-approved video here:
https://www.primrmed.com/cancer-clinical-trials/irradiant



Produced in partnership with Memorial Sloan Kettering Cancer Center | Himanshu Nagar | AngioDynamics | The NanoKnife System.

PRIMR aids sponsors in turning engagement data into effective action plans for clinical trial success. 📊🔬https://www.pri...
04/21/2026

PRIMR aids sponsors in turning engagement data into effective action plans for clinical trial success. 📊🔬

https://www.primrmed.com/

Make informed consent effortless with PRIMR’s video tools.Trusted, patient-friendly education from start to finish. 📋✅ht...
04/16/2026

Make informed consent effortless with PRIMR’s video tools.

Trusted, patient-friendly education from start to finish. 📋✅

https://www.primrmed.com/

PRIMR’s engagement insights empower sponsors to optimize recruitment and retention strategies in clinical trials. 🏥🎯http...
04/14/2026

PRIMR’s engagement insights empower sponsors to optimize recruitment and retention strategies in clinical trials. 🏥🎯

https://www.primrmed.com/

04/13/2026

🎯 If your PSA is rising, it may signal recurrence that standard scans can miss. PSMA PET imaging in the AMPLIFY trial uses a newer tracer that could detect cancer spread more accurately. This may help guide better treatment decisions based on clearer imaging.

Learn more. Watch the IRB-approved video here:
https://www.primrmed.com/cancer-clinical-trials/amplify-trial

IRB-approved visuals support patient safety.



Produced in partnership with Clarity Pharmaceuticals.

IRB-approved visuals support patient safety.The AMPLIFY trial studies 64Cu-SAR-bisPSMA, an investigational PSMA PET tr...
04/13/2026

IRB-approved visuals support patient safety.

The AMPLIFY trial studies 64Cu-SAR-bisPSMA, an investigational PSMA PET tracer designed to detect more prostate cancer spread on scans, aiming to improve accuracy and guide better treatment decisions.

Watch the IRB-approved video here:
https://www.primrmed.com/cancer-clinical-trials/amplify-trial



Produced in partnership with Clarity Pharmaceuticals.

Address

Hartford, CT
06117

Website

Alerts

Be the first to know and let us send you an email when PRIMR posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category